Clinical trials
Observational Dilatation, Pathologic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 5 |
| Unknown status | 5 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cxlusa | 4 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2 |
| Technische Universität Dresden | 2 |
| Ankara University | 1 |
| Augusta University | 1 |
| DiaSorin Inc. | 1 |
| Dokuz Eylul University | 1 |
| Federico II University | 1 |
| Gildasio Castello de Almeida Junior | 1 |
| Instituto de Olhos de Goiania | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dilatation, Pathologic | 23 |
| Keratoconus | 8 |
| Astigmatism | 3 |
| Corneal Diseases | 3 |
| Cardiomyopathies | 2 |
| Constipation | 2 |
| Abdominal Pain | 1 |
| Acute Coronary Syndrome | 1 |
| Airway Obstruction | 1 |
| Arachnodactyly | 1 |
Trials
Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.